Cargando…
FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway
Hepatocellular carcinoma (HCC) is the third-leading cause of cancer deaths globally. Although considerable progress has been made in the treatment, clinical outcomes of HCC patients are still poor. Therefore, it is necessary to find novel prognostic factors upon which prevention and treatment strate...
Autores principales: | Ma, Dong, Liu, Pengpeng, Wen, Junjun, Gu, Yang, Yang, Zhangshuo, Lan, Jianwei, Fan, Haining, Liu, Zhisu, Guo, Deliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830510/ https://www.ncbi.nlm.nih.gov/pubmed/36632465 http://dx.doi.org/10.7150/ijbs.69784 |
Ejemplares similares
-
SBDS(R126T) rescues survival of sbds(−/−) zebrafish in a dose-dependent manner independently of Tp53
por: Oyarbide, Usua, et al.
Publicado: (2023) -
Dual regulation of p53 by the ribosome maturation factor SBDS
por: Hao, Qian, et al.
Publicado: (2020) -
Identification of 13 Key Genes Correlated With Progression and Prognosis in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis
por: Gu, Yang, et al.
Publicado: (2020) -
A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma
por: Guo, Deliang, et al.
Publicado: (2021) -
A Novel End-to-End Biliary-to-Biliary Anastomosis Technique for Iatrogenic Bile Duct Injury of Strasberg-Bismuth E1-4 Treatment: A Retrospective Study and in vivo Assessment
por: Ma, Dong, et al.
Publicado: (2021)